Jordan's third COVID-19 wave requires commitment to preventive protocols: Health ministry

Jordan

Published: 2021-11-21 16:52

Last Updated: 2021-11-27 14:00


Jordan's third COVID-19 wave requires commitment to preventive protocols: Health ministry
Jordan's third COVID-19 wave requires commitment to preventive protocols: Health ministry

The Secretary-General of the Ministry of Health for Epidemiological Affairs, Dr. Adel Balbisi, said Jordan has entered a third COVID-19 wave, due to the "high" number of infections, which reached about 20k cases per week, up by 5000 cases over the last week.

Balbisi also indicated that the percentage of positive tests increased to 8 percent, calling for adhering to preventive measures, social distancing, and receiving vaccination.

In statements to "Petra" on Sunday, Balbisi noted the capacity of hospitals designated to treat COCID-19 patients is "comfortable."

Occupancy rate of intensive care beds, isolation and ventilator beds, respectively, did not exceed 30 percent, as there are 3,500 isolation beds in the Ministry of Health hospitals, 1,200 in intensive care wards, and 1,000 ventilators, he pointed out.

The anti-COVID-19 vaccines are available in "sufficient and large" quantities, and that the ministry is able to administer 100,000 doses per day, according to Balbisi.

In this regard, he called on citizens and residents in the Kingdom to receive Covid-19 jabs in the designated centers, with the possibility of choosing the type of vaccine, without prior appointment.

Stressing the need to adhere to preventive protocols to keep sectors open, and continue in-person education, he said this commitment heads off curfews and implementation of any new related decisions.

Regarding the national COVID-19 immunization program, Balbisi indicated that the number of recipients of the first dose reached about 4.07 million, while the double-jabbed tally hit 3.66 million, adding that the number of target groups over the age of 18 stands at 6.4 million.

Access to safety requires more than 75% of the target group to be given two doses, he noted.